Page last updated: 2024-09-05

organophosphonates and Viremia

organophosphonates has been researched along with Viremia in 107 studies

Research

Studies (107)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (6.54)	18.2507
2000's	49 (45.79)	29.6817
2010's	48 (44.86)	24.3611
2020's	3 (2.80)	2.80

Authors

Authors	Studies
Bajpai, PS; Bukh, J; Dalegaard, MI; Fahnøe, U; Lundh, A; Ryom, L; Weis, N; Winckelmann, A	1
Boeckh, MJ; Brundage, TM; Hill, JA; Lanier, R; Marty, FM; Nichols, WG; Papanicolaou, GA; Zerr, DM	1
Ljungman, P	1
Cardona, DM; Detweiler, CJ; Mueller, SB; Prasad, VK; Saullo, JL; Sung, AD	1
Kinsey, S; Meena, JP; Phillips, RS	1
Derniame, S; Gaspar, HB; Gilmour, K; Hiwarkar, P; Ip, W; McNicol, AM; Qasim, W; Veys, P; Zhan, H	1
DeVos, JM; Gaber, AO; Gaber, LW; Knight, RJ; Moore, LW; Patel, SJ	1
Benko, E; Blazkova, J; Casazza, JP; Chun, TW; Costiniuk, CT; Fauci, AS; Hallahan, CW; Kandel, G; Kaul, R; Kim, CJ; Koup, RA; Kovacs, C; Moir, S; Murray, D; Ostrowski, M; Shawn Justement, J	1
Alegría-Motte, C; Gómez García, M; González-Artacho, C; Rodríguez Sicilia, MJ	1
Amancha, PK; Ansari, AA; Hong, JJ; Rogers, K; Villinger, F	1
Berg, T; Chan, S; Dinh, P; Flaherty, JF; Kitrinos, KM; Manns, M; Marcellin, P; McHutchison, JG; Moeller, B; Trinh, H; Zoulim, F	1
Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X	1
Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ	1
Boyd, A; Delaugerre, C; Girard, PM; Gozlan, J; Lacombe, K; Maylin, S; Peytavin, G; Zoulim, F	1
Bartholomew, ML; Chang, A; Tsai, N; Tsai, PJ; Yamada, S	1
Cianciolo, R; Derebail, VK; Lachiewicz, AM; Miller, MB	1
Gerlich, WH	1
DeVos, JM; Gaber, AO; Gaber, LW; Knight, RJ; Kuten, SA; Patel, SJ	1
Ball, LM; Bredius, RG; Bresters, D; Jol-van der Zijde, CM; Kollen, WJ; Lankester, AC; Lugthart, G; Oomen, MA; Schilham, MW; Smiers, FJ; van Tol, MJ; Vermont, CL	1
Boruchov, AM; Chittick, G; Glezerman, IG; Lee, YJ; Momméja-Marin, H; Papanicolaou, GA; Seshan, SV; Young, JW	1
Braverman, RS; Caruso Brown, AE; Cohen, MN; Giller, R; Levin, MJ; Rooney, JF; Tong, S	1
Amancha, PK; Ansari, AA; Blanchard, EL; Byrareddy, SN; Connor-Stroud, F; Gumber, S; Hong, JJ; Hoxie, JA; Hunter, E; Rogers, KA; Santangelo, PJ; Schuster, DM; Strait, K; Vidakovic, B; Villinger, F; Zurla, C	1
Dandri, M; Lütgehetmann, M; Murray, JM; Petersen, J; Stancevic, O; Wursthorn, K	1
Astor, BC; Djamali, A; Mandelbrot, D; Mohamed, M; Muth, B; Panzer, SE; Parajuli, S; Zhong, W	1
Carrington, M; Davis, B; Duh, FM; Jean-Pierre, P; La Roche, M; Markowitz, M; Mehandru, S; Mohri, H; Poles, M; Prada, N	1
Hsu, R; Lanier, ER; Oie, KL; Pappa, KA; Ross, LL; Rouse, EG	1
Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK	1
Brenchley, J; Buckler-White, A; Igarashi, T; Kubo, M; Lafont, B; Lee, W; Martin, MA; Nishimura, Y; Shingai, M	1
Brancaccio, G; Gaeta, GB; Nardiello, S; Precone, V; Sgrò, G; Stornaiuolo, G	1
Andreotti, M; Antonelli, G; Ceccarelli, G; d'Ettorre, G; Massetti, P; Mastroianni, CM; Rizza, C; Turriziani, O; Vella, S; Vullo, V	1
Patel, S; Slatter, M; Valappil, M; Waugh, S	1
Funk, A; Helm, M; Olotu, C; Rockstroh, JK; Schildgen, O; Sirma, H; Zöllner, B	1
Cohen, C; DeJesus, E; Elion, R; Gerondelis, P; Ha, B; Horton, J; Lanier, ER; Ross, LL; Rouse, E	1
Doucette, S; Fergusson, DA; Gill, JS; Jaswal, D; Johnston, O; Knoll, GA	1
Engström, L; Lewensohn-Fuchs, I; Ljungman, P; Omar, H; Orvell, C; Pérez-Bercoff, L; Vuong, GK; Yun, Z	1
Alteri, C; Angelico, M; Bernassola, M; Bertoli, A; Cappiello, G; Cassola, G; Ceccherini-Silberstein, F; De Sanctis, GM; Feasi, M; Gallinaro, V; Gori, C; Gubertini, G; Longo, R; Marcuccilli, F; Micheli, V; Parruti, G; Perno, CF; Romano, S; Salpini, R; Spanò, A; Svicher, V; Ursitti, A; Visca, M	1
Anzidei, G; Baroncelli, S; Cauda, R; Cusato, M; De Luca, A; Fantoni, M; Floridia, M; Pinnetti, C; Regazzi, M; Tamburrini, E; Tozzi, V; Villani, P	1
Boucher, CA; van de Vijver, DA	1
D'Aquila, RT; Geretti, AM; Horton, JH; Kheshti, A; Oie, K; Pappa, K; Raffanti, S; Ross, LL; Rouse, E	1
Cao, W; Li, TS; Qiu, ZF	1
Andreoni, M; Bertoli, A; Ceccarelli, L; Perno, CF; Salpini, R; Sarrecchia, C; Sordillo, P; Svicher, V; Volpi, A	1
Holodniy, M; Schirmer, P; Winters, M	1
da Silva, AC; Gianini, RJ; Gomes-Gouvea, MS; Guastini, CF; Leite, AG; Martins, LG; Mendes-Correa, MC; Pinho, JR; Silva, MH; Uip, DE	1
Berg, T; Brown, A; Buggisch, P; Buti, M; Janssen, HL; Lampertico, P; Lutgehetmann, M; Petersen, J; Ratziu, V; Sarrazin, C; Schollmeyer, J; Sterneck, M; Wedemeyer, H; Zoulim, F	1
Barker, K; Daozhen, X; Dixon, J; Guangbi, Y; Hao, W; Hong, R; JinLin, H; Junqi, N; Minde, Z; Xiaqiu, Z; Yagang, C; Yaozong, W; Yimin, M; Youming, C; Yuming, W	1
Arterburn, S; Cheng, AK; Chuck, SL; da Silva, MT; de Aquino, MZ; de Carvalho, AP; Della Negra, M; Enejosa, JV; Liu, YP; Pinto, J; Rhee, MS; White, K	1
El-Zoghby, Z; Herrmann, S; Keddis, M; Leung, N; Sethi, S	1
Bunchorntavakul, C; Ghany, MG; Huang, WM; Karsdon, J; Mi, LJ; Pan, CQ; Reddy, KR; Singhvi, G	1
Acosta, EP; Barreca, ML; Chirullo, B; Collins, M; Della Corte, A; Greenhouse, J; Iraci, N; Lewis, MG; Norelli, S; Savarino, A; Shytaj, IL; Yalley-Ogunro, J	1
Abel, K; Canfield, DR; Forthal, DN; Geng, Y; Heneine, W; Jayashankar, K; Johnson, JA; LaBranche, CC; Landucci, G; Lipscomb, J; Montefiori, D; Tarara, RP; Trott, KA; Van Rompay, KK	1
Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H	1
Fung, J; Hung, IF; Lai, CL; Liu, K; Seto, WK; Wong, DK; Yuen, JC; Yuen, MF	1
Arzumanyan, A; Bassit, L; Clayton, MM; Feitelson, MA; Kohler, JJ; Obikhod, A; Schinazi, RF; Sun, B	1
Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y	1
Al-Mohareb, F; Aljurf, M; Barba, P; Cappelli, B; Cesaro, S; Cordonnier, C; Fagioli, F; Faraci, M; Floisand, Y; Greil, J; Martino, R; Nozzoli, C; Panizzolo, IS; Pillon, M; Santarone, S; Schroyens, W; Tridello, G	1
Daucher, M; Davey, RT; Kohli, A; Kottilil, S; Masur, H; Sarin, SK; Sherman, AC; Trehanpati, N	1
Chevallier, M; Cova, L; Gibbs, CS; Guerret, S; Jamard, C; Le Guerhier, F; Thermet, A; Trépo, C; Zoulim, F	1
Barcena Marugan, R; Cid Gomez, L; Lopez Serrano, P	1
Bischofberger, N; Blanchard, J; Cline, AN; Lifson, JD; Pandrea, I; Piatak, M; Purcell, J; Rossio, JL; Veazey, RS	1
Bernardin, F; Delwart, EL; Garg, S; Magierowska, M; Miller, MD; Staprans, S; Van Rompay, KK	1
Bischofberger, N; Lawson, JR; Marthas, ML; Pahar, B; Singh, RP; Sodora, DL; Van Rompay, KK; Wingfield, C	1
Bailey, KW; Beadle, JR; Hostetler, KY; Sidwell, RW; Smee, DF; Wong, MH	1
Agher, R; Calvez, V; Dominguez, S; Duvivier, C; Ghosn, J; Katlama, C; Marcelin, AG; Paris, L; Peytavin, G; Tubiana, R; Valantin, MA; Wirden, M	1
Cote, PJ; Delaney, WE; Gerin, JL; Jacob, JR; Korba, BE; Tennant, BC; Toshkov, I	1
Imamura, T; Imashuku, S; Ishida, H; Morimoto, A; Mukouyama, A; Shin-Nakai, N; Teramura, T; Yoshihara, T	1
Havlir, DV; Ignacio, CC; Koelsch, KK; Lu, B; Margot, N; Miller, MD; Strain, MC; Wong, JK	1
Dalmau, D; Ferrer, E; Gatell, JM; Iniguez, D; Knobel, H; Leon, A; Niubo, J; Podzamczer, D; Polo, C; Ruiz, I	1
Carruth, LM; Clements, JE; Li, M; Mankowski, JL; Miller, MD; Queen, LA; Shen, A; Siliciano, RF; Tarwater, PM; Zink, MC	1
Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J	1
Butler, SD; Cote, PJ; Delaney, WE; George, AL; Gerin, JL; Korba, BE; Menne, S; Tennant, BC; Tochkov, IA; Xiong, S	1
Andreone, P; Bernardi, M; Calza, L; Chiodo, F; Giuliani, R; Manfredi, R; Tadolini, M; Trevisani, F; Verucchi, G; Zambruni, A	1
Angarano, G; Fazio, V; Palumbo, E; Saracino, A; Scotto, G; Tartaglia, A	1
Berger, A; Bickel, M; Carlebach, A; Klauke, S; Lutz, T; Staszewski, S; Stephan, C; Stuermer, M	1
Brosgart, C; Chaix, ML; Currie, G; Fontaine, H; Morales, E; Nalpas, B; Pol, S; Serpaggi, J; Vallet-Pichard, A; Varaut, A; Verkarre, V	1
Hariharan, S	1
Allen, TM; Bazmi, A; Fuller, DH; Fuller, JT; Haynes, JR; McMahon, CW; Mothe, B; Murphey-Corb, M; Rajakumar, PA; Shipley, T; Trichel, AM; Watkins, DI; Wu, MS	1
Funk, A; Gerlich, WH; Hartmann, H; Helm, M; Olotu, C; Rockstroh, JK; Schildgen, O; Sirma, H; Wend, UC; Will, H; Willems, WR	1
Antunes, F; Chiesi, A; Goebel, FD; Katlama, C; Knysz, B; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P	1
Gerlich, W; Helm, M; Schildgen, O	1
Cervasi, B; Engram, J; Fraternale, A; Lawson, B; Magnani, M; Menotta, M; Paiardini, M; Perno, CF; Piedimonte, G; Serafini, S; Silvestri, G; Staprans, SI	1
Allice, T; Cerutti, F; Colucci, G; Franchello, A; Gabella, S; Ghisetti, V; Marzano, A; Pittaluga, F; Varetto, S	1
Aebi, C; Leibundgut, K; Ridolfi Lüthy, A; Steiner, I; Wagner, B	1
Amoroso, A; Chan-Tack, KM; Kopack, AM; Polk, C	1
Bischofberger, N; Blackwood, EJ; Heneine, W; Johnson, JA; Lipscomb, J; Marthas, ML; Matthews, TB; North, TW; Pedersen, NC; Singh, RP; Van Rompay, KK	1
Bae, SH; Chang, UI; Choi, JY; Jang, JW; Lee, YC; Sun, HS; Wie, SH; Yang, JM; Yoon, SK	1
Bonino, F; Brunetto, MR; Ciccorossi, P; Coco, B; Colombatto, P; Flichman, D; Maina, AM; Moriconi, F; Oliveri, F; Sacco, R	1
Adams, MM; Moyer, RW; Rice, AD	1
Colombo, S; Del Poggio, P; Jamoletti, C; Oggionni, M; Puhalo, V; Zaccanelli, M	1
Anderson, J; Bowden, S; Cooksley, H; Hui, CK; Lau, GK; Lewin, S; Locornini, S; Mondou, E; Naoumov, NV; Perelson, AS; Powers, KA; Ribeiro, RM; Rousseau, F; Shudo, E; Sorbel, J	1
Adams, DR; Butera, S; Folks, TM; Garcia-Lerma, JG; Heneine, W; Kersh, EN; Luo, W; Mitchell, J; Otten, RA	1
Heim, A; Mattner, F; Meissner, B; Sykora, KW	1
Bischofberger, N; Fauci, AS; Hirsch, VM; Kinter, A; Lifson, JD; Lloyd, AL; Nowak, MA; Vasquez, GM; Wahl, LM; Williams, J; Wiltrout, TA	1
Aguirre, NL; Berardi, CJ; Bischofberger, N; Lietman, PS; Marthas, ML; Pedersen, NC; Van Rompay, KK	1
Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA	1
Chopra, KB; Gilson, RJ; Jaffe, HS; Murray-Lyon, IM; Nelson, MR; Newell, AM; Rice, SJ; Tedder, RS; Toole, J; Weller, IV	1
Crabbs, C; Greenhouse, J; Lewis, MG; Lisziewicz, J; Lori, F; Silvera, P; Tinelli, C; Varga, G; Wagner, W; Xu, J; Yalley-Ogunro, J; Zinn, DE	1
Torres, G	1
Bailey, KW; Sidwell, RW; Smee, DF	1
Basara, N; Kiehl, MG	1
Castagnola, E; Chierici, M; Cristina, E; Lanino, E; Miano, M; Morreale, G	1
Andreoni, M; Carolo, G; Concia, E; Gatti, F; Mazzi, R; Nicastri, E; Parisi, SG; Sarmati, L; Uccella, I	1
Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H	1
Cohen, J	1
Bohm, R; Hitchcock, MJ; Huang, JL; Martin, JC; Soike, KF; Zhang, JY	1
Balzarini, J; Bronson, R; De Clercq, E; Jaenisch, R; Lee, JS; Mullaney, S; Ruprecht, RM; Sharpe, AH	1

Reviews

4 review(s) available for organophosphonates and Viremia

Article	Year
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation, 2010, May-15, Volume: 89, Issue:9 Topics: Antiviral Agents; BK Virus; Cidofovir; Cohort Studies; Creatinine; Cytosine; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Randomized Controlled Trials as Topic; Reoperation; Survival Rate; Treatment Failure; Tumor Virus Infections; Viremia	2010
The risk of HIV drug resistance following implementation of pre-exposure prophylaxis. Current opinion in infectious diseases, 2010, Volume: 23, Issue:6 Topics: Adenine; Animals; Anti-HIV Agents; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; HIV; HIV Infections; Humans; Organophosphonates; Risk Assessment; Tenofovir; Viremia	2010
Invasive adenoviral infection in a recipient of unrelated bone marrow transplantation: Problems with diagnostic PCR. Pediatric blood & cancer, 2005, Volume: 44, Issue:4 Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Cidofovir; Cytosine; Diagnostic Errors; Female; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Polymerase Chain Reaction; Postoperative Complications; Transplantation, Homologous; Viremia	2005
BK virus nephritis after renal transplantation. Kidney international, 2006, Volume: 69, Issue:4 Topics: Antibodies, Viral; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Graft Survival; Humans; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Nephritis; Organophosphonates; Polyomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Tumor Virus Infections; Viremia	2006

Trials

17 trial(s) available for organophosphonates and Viremia

Article	Year
Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation. British journal of haematology, 2013, Volume: 161, Issue:3 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Antigens, Viral; Antiviral Agents; Capsid Proteins; Child; Chromatography, Liquid; Cidofovir; Combined Modality Therapy; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunomagnetic Separation; Immunosuppressive Agents; Immunotherapy, Adoptive; Infant; Infant, Newborn; Interferon gamma Receptor; Interferon-gamma; Lymphocyte Transfusion; Organophosphonates; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Interferon; Ribavirin; T-Cell Antigen Receptor Specificity; T-Lymphocyte Subsets; Transplantation, Homologous; Viremia	2013
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. Journal of hepatology, 2014, Volume: 60, Issue:4 Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Male; Organophosphonates; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load; Viremia	2014
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications. Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:2 Topics: Adenine; Adult; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load; Viremia; Virus Replication	2014
Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women. Digestive diseases and sciences, 2014, Volume: 59, Issue:11 Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Odds Ratio; Organophosphonates; Pregnancy; Risk Factors; Tenofovir; Viremia; Young Adult	2014
Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Acute Kidney Injury; Adenovirus Infections, Human; Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Humans; Male; Organophosphonates; Pilot Projects; Polyomavirus Infections; Viremia	2015
Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:1 Topics: Adenine; Adolescent; Adult; Antiviral Agents; Asian People; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Mutation; Organophosphonates; Treatment Outcome; Viral Load; Viremia; Young Adult	2012
A randomized study of tenofovir disoproxil fumarate in treatment-experienced HIV-1 infected adolescents. The Pediatric infectious disease journal, 2012, Volume: 31, Issue:5 Topics: Adenine; Adolescent; Anti-HIV Agents; Child; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Outcome; Viremia	2012
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation. Bone marrow transplantation, 2013, Volume: 48, Issue:6 Topics: Adolescent; Adult; Allografts; Antiviral Agents; BK Virus; Child, Preschool; Cidofovir; Cystitis; Cytosine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infant; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Time Factors; Viral Load; Viremia	2013
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir. AIDS research and human retroviruses, 2013, Volume: 29, Issue:4 Topics: Adenine; Adult; Antiviral Agents; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Double-Blind Method; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Immunity, Cellular; Male; Middle Aged; Organophosphonates; Programmed Cell Death 1 Receptor; Prospective Studies; T-Lymphocytes, Regulatory; Viral Load; Viremia	2013
Early virological failure with a combination of tenofovir, didanosine and efavirenz. Antiviral therapy, 2005, Volume: 10, Issue:1 Topics: Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Organophosphonates; Oxazines; Pyrimidinones; RNA, Viral; Tenofovir; Time Factors; Treatment Failure; Viremia	2005
Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B. The new microbiologica, 2005, Volume: 28, Issue:3 Topics: Adenine; Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Viremia	2005
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency. Transplantation, 2005, Oct-27, Volume: 80, Issue:8 Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Renal Dialysis; Renal Insufficiency; Viremia	2005
Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. World journal of gastroenterology, 2007, Aug-14, Volume: 13, Issue:30 Topics: Adenine; Adult; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Viremia	2007
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. Antiviral therapy, 2007, Volume: 12, Issue:5 Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; DNA, Viral; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunity, Cellular; Kinetics; Male; Middle Aged; Models, Immunological; Organophosphonates; T-Lymphocytes; Treatment Outcome; Viral Load; Viremia; Virus Replication	2007
A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection. Journal of viral hepatitis, 1999, Volume: 6, Issue:5 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Organophosphonates; Treatment Outcome; Viral Load; Viremia	1999
Opportunistic infection highlights from the 35th ICAAC. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia	1995
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation	2001

Other Studies

86 other study(ies) available for organophosphonates and Viremia

Article	Year
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2022, Volume: 150-151 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Mutation; Organophosphonates; RNA-Directed DNA Polymerase; Tenofovir; Viremia	2022
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT. Blood, 2020, 04-23, Volume: 135, Issue:17 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Cytosine; DNA, Viral; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Incidence; Male; Middle Aged; Organophosphonates; Prognosis; Randomized Controlled Trials as Topic; Roseolovirus Infections; United States; Viral Load; Viremia; Virus Activation; Young Adult	2020
Is antiviral therapy against HHV-6B beneficial? Blood, 2020, 04-23, Volume: 135, Issue:17 Topics: Antiviral Agents; Cytosine; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Incidence; Organophosphonates; Roseolovirus Infections; Viremia	2020
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD. Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:6 Topics: Adenoviridae; Adenoviridae Infections; Autografts; Child, Preschool; Colon; Cytosine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Octreotide; Organophosphonates; Viremia	2018
Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant. Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:7 Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Organophosphonates; Salvage Therapy; Viremia	2019
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis. Transplantation, 2013, Apr-15, Volume: 95, Issue:7 Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cytosine; Early Diagnosis; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Mass Screening; Middle Aged; Multivariate Analysis; Organophosphonates; Polyomavirus Infections; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Texas; Time Factors; Tumor Virus Infections; Viral Load; Viremia; Young Adult	2013
Effect of antiretroviral therapy on HIV reservoirs in elite controllers. The Journal of infectious diseases, 2013, Nov-01, Volume: 208, Issue:9 Topics: Adenine; Anti-HIV Agents; Asymptomatic Diseases; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV-1; Humans; Immunity, Innate; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Viremia; Virus Replication	2013
[Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents]. Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1 Topics: Adalimumab; Adenine; Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azathioprine; Crohn Disease; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Organophosphonates; Tumor Necrosis Factor-alpha; Viral Load; Viremia; Virus Activation	2014
In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit. Journal of immunology (Baltimore, Md. : 1950), 2013, Dec-15, Volume: 191, Issue:12 Topics: Adenine; Animals; Anti-Retroviral Agents; Antibodies, Monoclonal; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation, Preclinical; Emtricitabine; Histocompatibility Antigens Class I; Immunity, Cellular; Immunoglobulin Fc Fragments; Immunotherapy; Lymphokines; Macaca mulatta; Organophosphonates; Programmed Cell Death 1 Receptor; Recombinant Proteins; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Solubility; Tenofovir; Viremia; Zalcitabine	2013
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation, 2014, Volume: 49, Issue:5 Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs Host Disease; Health Care Costs; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Incidence; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Risk Factors; Transplantation, Homologous; Tumor Virus Infections; Viremia; Young Adult	2014
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. Journal of viral hepatitis, 2014, Volume: 21, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia	2014
Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4 Topics: Adenoviridae; Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Kidney Transplantation; Nephritis, Interstitial; Organophosphonates; Respiratory Tract Infections; Viremia; Young Adult	2014
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy. Intervirology, 2014, Volume: 57, Issue:3-4 Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Viral Load; Viremia	2014
Observations on the use of cidofovir for BK virus infection in renal transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:6 Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections; Viral Load; Viremia	2014
The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cohort Studies; Cytosine; DNA, Viral; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Killer Cells, Natural; Lymphocyte Count; Lymphocyte Depletion; Male; Organophosphonates; T-Lymphocytes; Transplantation, Homologous; Viral Load; Viremia	2015
Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:5 Topics: BK Virus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Male; Middle Aged; Organophosphonates; Polyomavirus; Polyomavirus Infections; Tumor Virus Infections; Viremia	2015
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nature methods, 2015, Volume: 12, Issue:5 Topics: Adenine; Animals; Anti-Retroviral Agents; Copper Radioisotopes; Deoxycytidine; Emtricitabine; Immunohistochemistry; Male; Membrane Glycoproteins; Naphthyridines; Organophosphonates; Positron-Emission Tomography; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Simian Immunodeficiency Virus; Tenofovir; Viral Envelope Proteins; Viremia; Virus Replication; Whole Body Imaging	2015
Variability in long-term hepatitis B virus dynamics under antiviral therapy. Journal of theoretical biology, 2016, Feb-21, Volume: 391 Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Liver; Male; Models, Biological; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Viremia	2016
In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:3 Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Plasma Exchange; Polyomavirus Infections; Prognosis; Risk Factors; Tumor Virus Infections; Viremia	2016
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course. Journal of acquired immune deficiency syndromes (1999), 2008, Oct-01, Volume: 49, Issue:2 Topics: Adenine; Adult; Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; Chemoprevention; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; HLA Antigens; Humans; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Organophosphonates; Phylogeny; Receptors, CCR5; Sequence Alignment; Tenofovir; Time Factors; Viral Load; Viremia	2008
Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations. Antiviral therapy, 2008, Volume: 13, Issue:5 Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Outcome; Viremia	2008
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV medicine, 2009, Volume: 10, Issue:4 Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia	2009
Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease. Journal of virology, 2009, Volume: 83, Issue:14 Topics: Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; HIV Antibodies; HIV Infections; Humans; Injections; Macaca mulatta; Molecular Sequence Data; Organophosphonates; Sequence Alignment; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Time Factors; Viremia; Virus Replication	2009
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. Le infezioni in medicina, 2009, Volume: 17, Issue:2 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Salvage Therapy; Tenofovir; Viremia	2009
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:4 Topics: Adenine; Anti-HIV Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Mutation; Organophosphonates; Prospective Studies; Tenofovir; Viremia; Zidovudine	2009
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Adenine; Antiviral Agents; Bone and Bones; Bone Diseases; Double-Blind Method; Drug Approval; Europe; Fractures, Bone; Hepatitis B, Chronic; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication	2009
Persistent adenoviraemia in an infant following haematopoietic stem cell transplantation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 47, Issue:1 Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Feces; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphocyte Count; Male; Mothers; Organophosphonates; Severe Combined Immunodeficiency; Viral Load; Viremia	2010
Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy. Journal of clinical microbiology, 2010, Volume: 48, Issue:2 Topics: Adenine; Adult; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Molecular Sequence Data; Mutation, Missense; Organophosphonates; Selection, Genetic; Sequence Alignment; Tenofovir; Treatment Failure; Viremia; Young Adult	2010
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Organophosphonates; RNA, Viral; Tenofovir; Treatment Failure; Viremia; Young Adult; Zidovudine	2010
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:5 Topics: Adenoviridae Infections; Adult; Antiviral Agents; Asymptomatic Infections; Child; Child, Preschool; Cidofovir; Cohort Studies; Cytosine; DNA, Viral; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load; Viremia; Young Adult	2010
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:12 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Viral Load; Viremia	2010
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Tenofovir; Viral Load; Viremia	2010
More research needed to find new HIV-suppressive functions of cytotoxic T cells. Immunotherapy, 2010, Volume: 2, Issue:2 Topics: Adenine; Animals; Combined Modality Therapy; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Lymphocyte Depletion; Macaca mulatta; Organophosphonates; Simian Acquired Immunodeficiency Syndrome; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Tenofovir; Viral Load; Viremia	2010
Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing. AIDS research and human retroviruses, 2011, Volume: 27, Issue:2 Topics: Adenine; Dideoxynucleosides; HIV-1; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Viremia	2011
Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients. World journal of gastroenterology, 2011, May-07, Volume: 17, Issue:17 Topics: Adenine; ADP-ribosyl Cyclase 1; Adult; CD3 Complex; Female; Hepatitis B, Chronic; Humans; Male; Membrane Glycoproteins; Middle Aged; Organophosphonates; T-Lymphocyte Subsets; Viremia	2011
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. Infection, 2011, Volume: 39, Issue:4 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Bone Marrow; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Italy; Organophosphonates; Tenofovir; Treatment Outcome; Viremia	2011
HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:3 Topics: Adenine; Antiviral Agents; Coinfection; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viral Load; Viremia	2011
Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil. BMC infectious diseases, 2011, Sep-20, Volume: 11 Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia	2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. Journal of hepatology, 2012, Volume: 56, Issue:3 Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Internationality; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viremia; Young Adult	2012
Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012, Volume: 59, Issue:6 Topics: Acute Kidney Injury; Adenoviridae Infections; Adult; Antineoplastic Combined Chemotherapy Protocols; Cidofovir; Cord Blood Stem Cell Transplantation; Cytosine; Fetal Blood; Follow-Up Studies; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Nephritis, Interstitial; Organophosphonates; Risk Assessment; Severity of Illness Index; Treatment Outcome; Unrelated Donors; Viremia	2012
Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Digestive diseases and sciences, 2012, Volume: 57, Issue:9 Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Drug Administration Routes; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Organophosphonates; Phosphorous Acids; Pregnancy; Retrospective Studies; Viremia	2012
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. PLoS pathogens, 2012, Volume: 8, Issue:6 Topics: Adenine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Flow Cytometry; Fluorescent Antibody Technique; Macaca mulatta; Maraviroc; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Sulfonamides; T-Lymphocyte Subsets; Tenofovir; Triazoles; Viral Load; Viremia	2012
Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Retrovirology, 2012, Jul-17, Volume: 9 Topics: Adenine; Alleles; Animals; Antibodies, Viral; Antibody Formation; Antiviral Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Disease Models, Animal; Genes, MHC Class I; Genotyping Techniques; Immunity, Cellular; Lymphocyte Activation; Macaca mulatta; Neutralization Tests; Organophosphonates; RNA-Directed DNA Polymerase; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Time Factors; Treatment Outcome; Viremia; Virus Replication	2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy. Antiviral therapy, 2012, Volume: 17, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia	2012
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir. Antiviral therapy, 2012, Volume: 17, Issue:7 Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Predictive Value of Tests; Statistics, Nonparametric; Time Factors; Treatment Outcome; Viremia; Young Adult	2012
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Adenine; Animals; Antiviral Agents; Cell Line; Deoxycytidine; Drug Combinations; Drug Interactions; Emtricitabine; Hepatitis B; Hepatitis B virus; Mice; Mice, Nude; Organophosphonates; Phosphorylation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication	2012
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:1 Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross-Over Studies; Cytosine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Probenecid; Tumor Virus Infections; Viremia	2013
Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model. Journal of hepatology, 2003, Volume: 38, Issue:3 Topics: Adenine; Animals; Antibody Formation; Antiviral Agents; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Immunization; Liver; Organophosphonates; Vaccines, DNA; Viremia; Virus Replication	2003
Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine. Transplantation proceedings, 2003, Volume: 35, Issue:5 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Recurrence; Treatment Failure; Viremia	2003
Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge. Journal of medical primatology, 2003, Volume: 32, Issue:4-5 Topics: Adenine; Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; DNA Primers; Gene Products, env; Gene Products, gag; Intestines; Lymphoid Tissue; Macaca mulatta; Male; Organophosphonates; Organophosphorus Compounds; Retroviridae Proteins, Oncogenic; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Fusion Proteins; Viral Load; Viremia	2003
Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques. Journal of virology, 2004, Volume: 78, Issue:5 Topics: Adenine; Animals; DNA Mutational Analysis; Drug Resistance, Viral; Genotype; Longitudinal Studies; Macaca mulatta; Male; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Tenofovir; Viremia	2004
CD8+-cell-mediated suppression of virulent simian immunodeficiency virus during tenofovir treatment. Journal of virology, 2004, Volume: 78, Issue:10 Topics: Adenine; Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viremia; Virus Replication	2004
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. International journal of antimicrobial agents, 2004, Volume: 23, Issue:5 Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Heart; Liver; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Oxygen; Purines; Respiratory Tract Infections; Ribavirin; Salivary Glands; Spleen; Treatment Outcome; Vaccinia; Vaccinia virus; Viral Plaque Assay; Viremia	2004
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level. Journal of acquired immune deficiency syndromes (1999), 2004, Jul-01, Volume: 36, Issue:3 Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Outcome; Viremia	2004
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral research, 2004, Volume: 63, Issue:2 Topics: Adenine; Administration, Oral; Amino Acid Motifs; Amino Acid Substitution; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Virus, Woodchuck; Lamivudine; Marmota; Mutation, Missense; Organophosphonates; Protein Structure, Tertiary; Viremia; Virus Replication	2004
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. The Journal of infectious diseases, 2005, Apr-01, Volume: 191, Issue:7 Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Oxazines; RNA, Viral; Stavudine; Tenofovir; Viremia	2005
SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. Journal of medical primatology, 2005, Volume: 34, Issue:3 Topics: Adenine; Animals; Anti-Retroviral Agents; Drug Therapy, Combination; Emtricitabine; Immunity, Cellular; Interferon-gamma; Linear Models; Macaca nemestrina; Organophosphonates; Primate Diseases; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes; Tenofovir; Viremia; Zalcitabine	2005
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine	2005
Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:7 Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Humans; Marmota; Organophosphonates; Tenofovir; Treatment Outcome; Viremia; Virus Replication	2005
Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. Transplant infectious disease : an official journal of the Transplantation Society, 2005, Volume: 7, Issue:1 Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Combination; Herpesvirus 8, Human; Humans; Immunocompromised Host; Liver Transplantation; Male; Middle Aged; Organophosphonates; Sarcoma, Kaposi; Viral Load; Viremia	2005
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6 Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Genes, pol; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load; Viremia; Virus Replication	2005
DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued. Virology, 2006, Apr-25, Volume: 348, Issue:1 Topics: Adenine; Animals; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cell Proliferation; Disease Progression; Epitopes, T-Lymphocyte; Gene Products, gag; Gene Products, tat; Immunotherapy, Active; Macaca mulatta; Organophosphonates; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Statistics as Topic; Tenofovir; Vaccines, DNA; Viremia; Withholding Treatment	2006
Variant of hepatitis B virus with primary resistance to adefovir. The New England journal of medicine, 2006, Apr-27, Volume: 354, Issue:17 Topics: Adenine; Amino Acid Sequence; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Viremia	2006
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. AIDS (London, England), 2006, May-12, Volume: 20, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Viremia; Zidovudine	2006
Nonresponse to adefovir: host or virus dependent? Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 37, Issue:4 Topics: Adenine; Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; RNA, Viral; Treatment Failure; Viremia	2006
Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy. Journal of virology, 2006, Volume: 80, Issue:21 Topics: Adenine; Animals; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cercocebus atys; Drug Carriers; Erythrocytes; Female; Humans; Macrophages; Male; Myeloablative Agonists; Organophosphonates; Simian Acquired Immunodeficiency Syndrome; STAT1 Transcription Factor; T-Lymphocyte Subsets; Tenofovir; Vidarabine; Viremia; Virus Replication	2006
COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. Journal of clinical microbiology, 2007, Volume: 45, Issue:3 Topics: Adenine; Antiviral Agents; Automation; Biopsy; DNA, Viral; Drug Resistance, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Nucleic Acid Amplification Techniques; Organophosphonates; Polymerase Chain Reaction; Sensitivity and Specificity; Taq Polymerase; Viremia	2007
Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Adenovirus Infections, Human; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Child, Preschool; Cidofovir; Computer Systems; Cytosine; DNA, Viral; Fatal Outcome; Hepatitis, Viral, Human; Humans; Immunocompromised Host; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Organophosphonates; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine; Viremia	2008
Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection. AIDS patient care and STDs, 2007, Volume: 21, Issue:2 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine; Enfuvirtide; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Lopinavir; Male; Organophosphonates; Peptide Fragments; Pyrimidinones; Ritonavir; Tenofovir; Viral Load; Viremia	2007
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. Retrovirology, 2007, Apr-06, Volume: 4 Topics: Adenine; Amino Acid Substitution; Animals; Anti-HIV Agents; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Lymphocyte Depletion; Macaca; Mutation, Missense; Organophosphonates; RNA, Viral; Selection, Genetic; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Load; Viremia	2007
Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy. Journal of medical virology, 2007, Volume: 79, Issue:7 Topics: Adenine; Adult; Antiviral Agents; Base Sequence; DNA Mutational Analysis; DNA Primers; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Gene Products, pol; Genes, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Promoter Regions, Genetic; Viral Core Proteins; Viremia	2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleosides; Nucleotides; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viremia	2007
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox. Journal of virology, 2007, Volume: 81, Issue:20 Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Organophosphonates; Poxviridae Infections; Rabbits; Smallpox; Survival Rate; Vaccinia; Vaccinia virus; Viremia	2007
Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS research and human retroviruses, 2008, Volume: 24, Issue:4 Topics: Adenine; Animals; Anti-HIV Agents; Antibodies; Antibody Specificity; Antiviral Agents; CD8-Positive T-Lymphocytes; Chemoprevention; Deoxycytidine; Drug Administration Schedule; Drug Evaluation, Preclinical; Emtricitabine; HIV-1; Injections, Intravenous; Injections, Subcutaneous; Lymphocyte Count; Macaca mulatta; Organophosphonates; Reassortant Viruses; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Treatment Outcome; Viral Load; Viremia	2008
An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:5 Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Antiviral Agents; Blood; Bone Marrow Transplantation; Capsid Proteins; Child; Child, Preschool; Cidofovir; Cross Infection; Cytosine; Disease Outbreaks; DNA, Viral; Feces; Gastroenteritis; Genotype; Germany; Hepatitis, Viral, Human; Humans; Infant; Organophosphonates; Sequence Analysis, DNA; Viral Load; Viremia; Virus Shedding	2008
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. Journal of virology, 1997, Volume: 71, Issue:10 Topics: Adenine; AIDS Vaccines; Animals; Antiviral Agents; Cells, Cultured; Humans; Kinetics; Lymphocytes; Macaca nemestrina; Models, Theoretical; Organophosphonates; Polymerase Chain Reaction; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viral Vaccines; Viremia; Virus Replication	1997
Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection. AIDS (London, England), 1998, Jun-18, Volume: 12, Issue:9 Topics: Adenine; Animals; Animals, Newborn; Anti-HIV Agents; Antibodies, Viral; Dose-Response Relationship, Drug; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viremia	1998
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group. American journal of ophthalmology, 1998, Volume: 126, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia	1998
Control of SIV rebound through structured treatment interruptions during early infection. Science (New York, N.Y.), 2000, Nov-24, Volume: 290, Issue:5496 Topics: Adenine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Drug Administration Schedule; Hydroxyurea; Lymphocyte Activation; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; Random Allocation; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Load; Viremia; Virus Replication	2000
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1 Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox virus; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Nose; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Paranasal Sinuses; Pneumonia, Viral; Spleen; Vaccinia; Vaccinia virus; Viral Load; Viremia	2001
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Recurrence; Salvage Therapy; Time Factors; Transplantation, Homologous; Viral Matrix Proteins; Viremia	2001
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS (London, England), 2001, Oct-19, Volume: 15, Issue:15 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Disease Progression; DNA, Viral; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome; Viremia	2001
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting	2001
Vaccines. Monkey puzzles. Science (New York, N.Y.), 2002, Jun-28, Volume: 296, Issue:5577 Topics: Acquired Immunodeficiency Syndrome; Adenine; AIDS Vaccines; Animals; Anti-HIV Agents; Clinical Trials as Topic; Haplorhini; HIV; Humans; Killer Cells, Natural; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; SAIDS Vaccines; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viremia	2002
Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral research, 1991, Volume: 16, Issue:1 Topics: Administration, Oral; Animals; Antibodies, Viral; Antiviral Agents; Chickenpox; Chlorocebus aethiops; Cidofovir; Cytosine; Herpesvirus 3, Human; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Viremia	1991
Transplacental antiretroviral therapy with 9-(2-phosphonylmethoxyethyl)adenine is embryotoxic in transgenic mice. Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:9 Topics: Adenine; Animals; Antiviral Agents; Embryo, Mammalian; Female; Fetal Resorption; Litter Size; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Transgenic; Moloney murine leukemia virus; Organophosphonates; Pregnancy; Viremia; Zidovudine	1991